Glenmark Pharmaceuticals gets USFDA nod for contraceptive drugs

The company's current portfolio consists of 137 products authorised for distribution at the US marketplace and 61 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA.
Source: The Economic Times - Category: Consumer Health News Source Type: news